Sweden· SE-20231027000030
Tresiba FlexPen 100 enheter/ml Injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing insulin degludec, registered in Sweden by Novo Nordisk A/S.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Insulin Degludec
- Manufacturer
- Novo Nordisk A/S
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20231027000030
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin degludec in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRESIBANovo Nordisk A/S, Bagsvaerd
- United StatesInsulin DegludecNovo Nordisk Pharma, Inc.
- BelgiumRyzodeg 100 U/mlNovo Nordisk
- United KingdomTresiba FlexTouch 100units/ml solution for injection 3ml pre-filled pensNovo Nordisk Ltd
- FinlandTresibaOrifarm Oy
- SpainTRESIBA 100 UNIDADES/ML FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADANovo Nordisk A/S
- SwitzerlandTresiba FlexTouch 100 E/ml, InjektionslösungNovo Nordisk Pharma AG
- IcelandTresibaNovo Nordisk A/S*
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Tresiba Flexpen, Tresiba Flextouch
- Norway · Tresiba, Tresiba Flexpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dce7668e-96c5-45f8-abca-c7293b43a72a GET /v1/drugs/dce7668e-96c5-45f8-abca-c7293b43a72a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20231027000030",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20231027000030",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/tresiba"
}See everything about insulin degludec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.